Preview

Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery

Advanced search

Major Duodenal Papilla Cancer: Treatment and Prognosis

https://doi.org/10.16931/1995-5464.2016484-92

Abstract

The review presents key data of the world literature about the results of surgical and combined treatment of patients ith major duodenal papilla cancer and immunophenotypic heterogeneity. This causes the difference in the prognosis and treatment. These data are correlated in some degree with authors' own experience that is the largest in the world

About the Authors

Yu. I. Patyutko
N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
Russian Federation

Doct. of Med. Sci., Professor, Chief of the Surgical Department of Pancreatic and Liver Cancer, N.N. Blokhin Russian Cancer Research Center



A. G. Kotel'nikov
N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
Russian Federation

Doct. of Med. Sci., Professor, Leading Researcher of the Surgical Department of Pancreatic and Liver Cancer, N.N. Blokhin Russian Cancer Research Center



N. E. Kudashkin
N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
Russian Federation

Cand. of Med. Sci., Researcher of the Surgical Department of Pancreatic and Liver Cancer, N.N. Blokhin Russian Cancer Research Center



A. N. Polyakov
N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
Russian Federation

Cand. of Med. Sci., Researcher of the Surgical Department of Pancreatic and Liver Cancer, N.N. Blokhin Russian Cancer Research Center



E. A. Moroz
N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
Russian Federation

Cand. of Med. Sci., Senior Researcher of the Pathology Department, N.N. Blokhin Russian Cancer Research Center



E. V. Yastrebova
Chair of Oncology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Postgraduate Student, Chair of Oncology, I.M. Sechenov First Moscow State
Medical University



References

1. Schiergens T.S., Reu S., Neumann J., Renz B.W., Niess H., Boeck S., Heinemann V., Bruns C.J., Jauch K.W., Kleespies A. Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater. Surgery. 2015; 158 (1): 151–161. doi: 10.1016/j.surg.2015.02.001. PMID: 25819575.

2. Westgaard A., Pomianowska E., Clausen O.P.F., Gladhang I.P. Intestinal-type and pancreatobiliary-type adenocarcinomas: How does ampullary carcinoma differ from other periampullary malignancies? Ann. Surg. Oncol. 2013; 20 (2): 430–439. doi: 10.1245/s10434-012-2603-0. PMID: 22956064.

3. Neoptolemos J.P., Malcolm J.M., Cox T.F., Valle J.W., Palmer D.H., McDonald A.C., Carter R., Tebbutt N.C., Dervenis C., Smith D., Glimelius B., Charnley R.M., Lacaine F. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012; 308 (2): 147–156. doi: 10.1001/jama.2012.7352. PMID: 22782416.

4. Bahtia S., Miller R.C., Haddock M.G., Donohue J.H., Krishnan S. Adjuvant therapy for ampullary carcinomas: the Mayo clinic experience. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66 (2): 514–519. doi: 10.1016/j.ijrobp.2006.04.018. PMID: 16863684.

5. Lindell G., Borch K., Tingstendt B., Enell E.L., Ihse I. Management of cancer of the ampullary of Vater: Does local resection play a role? Digest. Surg. 2007; 20 (6): 511–515. doi: 10.1159/000073647. PMID: 14506332.

6. Fisher H.P., Zhou H. Pathogenesis and histomorphology of ampullary carcinoma and their precursor lesions. Review and individual findings. Pathologe. 2003; 24 (3): 196–203. doi: 10.1007/s00292-003-0617-x. PMID: 12739053.

7. Zhou H., Schaefer N., Wolff M., Fischer H.P. Carcinoma of the ampulla of Vater: comparative histologic/immunohisto chemical classification and follow-up. Am. J. Pathol. 2004; 28 (7): 875–882. PMID: 15223956.

8. WHO classification of tumors of the digestive system. Edited by F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise. Lyon, 2010. 417 p.

9. Kimura W., Futukawa N., Yamagata S. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. JPN J. Cancer Res. 1994; 85 (2): 161–166. doi: 10.1111/j.1349-7006.1994.tb02077.x. PMID: 7511574.

10. Albores-Saavedra J., Henson D.E., Klimstra D.S. Tumors of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Atlas Tumor Pathol. 2000; 27: 259–316.

11. Kumari N., Prabha K., Singh R.K., Baitha D.K., Krishnani N.Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry. Hum. Pathol. 2013; 44 (10): 2213–2219. doi: 10.1016/j.humpath.2013.05.003. PMID: 23834763.

12. Allema J.H. Surgical treatment of tumors of the pancreatic head region. 1994. 143 p.

13. Sikora S.S., Balachandran P., Dimri K., Rastogi N., Kumar A., Saxena R., Kapoor V.K. Adjuvant chemo-radiotherapy in ampullary cancer. EJSO. 2005; 31 (2): 158–163. doi: 10.1016/j.ejso.2004.08.013. PMID: 15698732.

14. Klein F., Dietmar J., Bahra M., Pelzer U., Puhl G., Krannich A., Andreou A., Gul S., Guckelberger O. Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenectomy. HPB Surg. 2014; 2014: ID970234. doi: 10.1155/2014/970234. PMID: 24723741.

15. Narang A.K., Miller R.C., Hsu Ch.C., Bhatia S., Pawlik T.M., Laheru D., Hruban R.H., Zhou J., Winter J.M., Haddock M.G., Donohue J.H., Schulick R.D., Wolfgang C.L., Cameron J.L., Herman J.M. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital – Mayo Clinic collaboration study. Radiat. Oncol. 2011; 6: 126. doi: 10.1186/1748-717X-6-126. PMID: 21951377.

16. Piorkowski R.J., Blievernicht S.W., Lawrence W. Jr., Madariaga J., Horsley J.S. 3rd, Neifeld J.P., Terz J.J. Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12-year period. Am. J. Surg. 1982; 143 (2): 189–193. doi: 10.1016/0002-9610(82)90064-2. PMID: 6174049.

17. Feng J.F., Zhou X.M., Mao W.M. Prognostic analysis of carcinoma of the ampulla of Vater: pancreaticoduodenectomy versus local resection. Hippokratia. 2012; 16 (1): 23–28. PMID: 23930053.

18. Colussi O., Voron T., Pozet A., Hammel P., Sauvanet A., Bachet J.B., Vaillant J.C., Rougier Ph., Nordlinger B., Berger A., Coriat R., Dousset B. Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort. EJSO. 2015; 41 (4): 520–526. doi: 10.1016/j.ejso.2015.01.010. PMID: 25680954.

19. Bassi C., Dervenis C., Butturini G., Fingerhut A., Yeo C., Izbicki J., Neoptolemos J., Sarr M., Traverso W., Buchler M. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005; 138 (1): 8–13. doi: 10.1016/j.surg.2005.05.001. PMID: 16003309.

20. Kim K., Chie E.K., Jang J.Y., Kim S.W., Han S.W., Oh D.Y., Im S.A., Kim T.Y., Bang Y.J., Ha S.W. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma. Clin. Transl. Oncol. 2012; 14 (5): 391–395. doi: 10.1007/s12094-012-0814-2. PMID: 22551547.

21. Chang D.K., Jamieson N.B., Johns A.L., Scarlett C.J., Pajic M., Chou A., Pinese M., Humphris J.L., Jones M.D., Toon C., Nagrial A.M., Chantrill L.A., Chin V.T., Pinho A.V., Rooman I., Cowley M.J., Wu J., Mead R.S., Colvin E.K., Samra J.S., Corbo V., Bassi C., Falconi M., Lawlor R.T., Crippa S., Sperandio N., Bersani S., Dickson E.J., Mohamed M.A., Oien K.A., Foulis A.K., Musgrove E.A., Sutherland R.L., Kench J.G., Carter C.R., Gill A.J., Scarpa A., McKay C.J., Biankin A.V. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater. J. Clin. Oncol. 2013; 31 (10): 1348–1356. doi: 10.1200/JCO.2012.46.8868. PMID: 23439753.

22. Shroff S., Overman M.J., Rashid A., Shroff R.T., Wang H., Chatterjee D., Katz M.H., Lee J.E., Wolff R.A., Abbruzzese J.L., Fleming J.B., Wang H. The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy. Arch. Pathol. Lab. Med. 2013; 137 (11): 1619–1626. doi: 10.5858/arpa.2012-0418-OA. PMID: 24168499.

23. Romiti A., Barucca V., Zullo A., Sarcina I., Di Rocco R., D'Antonio C., Latorre M., Marchetti P. Tumors of ampulla of Vater: a case series and review of chemotherapy options. World J. Gastrointest. Oncol. 2012; 4 (3): 60–67. doi: 10.4251/wjgo.v4.i3.60. PMID: 22468185.

24. Kim R., Chabot J., WasifSaif M. Adjuvant treatment for ampullary cancer “2011 ASCO Annual Meeting” Chicago I.L., USA; June 3–7, 2011.

25. Ahn D.H., Bekaii-Saab T. Ampullary cancer: an overview. ASCO Educational book, 2014: 112–115.

26. Klinkenbijl J.H., Jeekel J., Sahmoud T., van Pel R., Couvreur M.L., Veenhof C.H., Arnaud J.P., Gonzalez D.G., de Wit L.T., Hennipman A., Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann. Surg. 1999; 230 (6): 776–782. doi: 10.1097/00000658-199912000-00006. PMID: 10615932.

27. Morak M.J., van der Gaast A., Incrocci L., van Dekken H., Hermans J.J., Jeekel J., Hop W.C., Kazemier G., van Eijck C.H. Adjuvant intraarterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Ann. Surg. 2008; 248 (6): 1031–1041. doi: 10.1097/SLA.0b013e318190c53e. PMID: 19092348.

28. Neoptolemos J., Moore M., Cox T., Valle J., Palmer D., McDonald A., Carter R., Tebbutt N., Dervenis C., Smith D., Glimelius B., Coxon F., Lacaine F., Middleton M., Ghaneh P., Bassi1 C., Halloran C., Oláh A., Rawcliffe C., Büchler M. Ampullary cancer ESPAC-3 (v2) trial: a multicenter, international open-label randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of Vater. J. Clin. Oncol. 2011; 2a: abstr.

29. Takada T., Amano H., Yasuda H., Nimura Y., Matsushiro T., Kato H., Nagakawa T., Nakayama T. Is postoperative adjuvant chemotherapy usefull for gallbladder carcinoma? A phase III multicentre prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2012; 95 (8): 1685–1695. doi: 10.1002/cncr.10831. PMID: 12365016.


Review

For citations:


Patyutko Yu.I., Kotel'nikov A.G., Kudashkin N.E., Polyakov A.N., Moroz E.A., Yastrebova E.V. Major Duodenal Papilla Cancer: Treatment and Prognosis. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2016;21(4):84-92. (In Russ.) https://doi.org/10.16931/1995-5464.2016484-92

Views: 817


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-5464 (Print)
ISSN 2408-9524 (Online)